Nearly 80 healthcare organizations are calling on Congress to extend telehealth flexibilities established during the COVID-19 pandemic for at least two more years, warning that failure to do so would disrupt care and create uncertainty for patients and…
The Drug Enforcement Administration extended the flexibilities enacted during the COVID-19 pandemic that allows healthcare providers to prescribe specific controlled substances via telehealth.
CMS released the 2025 Physician Fee Schedule final rule Nov. 1, including a plan to preserve certain telehealth flexibilities beyond the expiring temporary pandemic-era measures.
The vast majority of patients who try virtual visits are willing to do them again, while nearly a quarter of patients say they’d switch physicians for virtual care access, according to the Deloitte Center for Health Solutions.